StonvexLoading…
StonvexStonvexStonvexCore line items from AEBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $455.55M | $1.53B | $998.25M | $526.93M |
Operating Income | $15.37M | $73.07M | $45.75M | $28.25M |
Net Income | $695.00K | $9.74M | $971.00K | $-235.00K |
EPS (Diluted) | $0.01 | $0.17 | $0.02 | $-0.01 |
Total Assets | $2.01B | $2.01B | $2.08B | $1.22B |
Total Liabilities | $1.19B | $1.19B | $1.26B | $859.66M |
Cash & Equivalents | $115.89M | $98.51M | $125.97M | $63.58M |
Free Cash Flow OCF − CapEx | $-19.67M | $-5.23M | $-34.98M | $-26.41M |
Shares Outstanding | 77.16M | 77.00M | 76.98M | 40.35M |